These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9485020)
1. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020 [TBL] [Abstract][Full Text] [Related]
2. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. Strasser JF; Fung LK; Eller S; Grossman SA; Saltzman WM J Pharmacol Exp Ther; 1995 Dec; 275(3):1647-55. PubMed ID: 8531140 [TBL] [Abstract][Full Text] [Related]
3. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S; J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drug transport to brain tumor. Arifin DY; Lee KY; Wang CH J Control Release; 2009 Aug; 137(3):203-10. PubMed ID: 19376172 [TBL] [Abstract][Full Text] [Related]
6. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951 [TBL] [Abstract][Full Text] [Related]
7. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720 [TBL] [Abstract][Full Text] [Related]
8. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer. Petros WP; Broadwater G; Berry D; Jones RB; Vredenburgh JJ; Gilbert CJ; Gibbs JP; Colvin OM; Peters WP Clin Cancer Res; 2002 Mar; 8(3):698-705. PubMed ID: 11895898 [TBL] [Abstract][Full Text] [Related]
9. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. Li KW; Dang W; Tyler BM; Troiano G; Tihan T; Brem H; Walter KA Clin Cancer Res; 2003 Aug; 9(9):3441-7. PubMed ID: 12960135 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel delivery to brain tumors from hydrogels: a computational study. Torres AJ; Zhu C; Shuler ML; Pannullo S Biotechnol Prog; 2011; 27(5):1478-87. PubMed ID: 21786432 [TBL] [Abstract][Full Text] [Related]
12. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766 [TBL] [Abstract][Full Text] [Related]
13. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. Sampath P; Hanes J; DiMeco F; Tyler BM; Brat D; Pardoll DM; Brem H Cancer Res; 1999 May; 59(9):2107-14. PubMed ID: 10232596 [TBL] [Abstract][Full Text] [Related]
14. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. Grossman SA; Reinhard C; Colvin OM; Chasin M; Brundrett R; Tamargo RJ; Brem H J Neurosurg; 1992 Apr; 76(4):640-7. PubMed ID: 1545259 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228 [TBL] [Abstract][Full Text] [Related]
16. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. Shikanov A; Vaisman B; Krasko MY; Nyska A; Domb AJ J Biomed Mater Res A; 2004 Apr; 69(1):47-54. PubMed ID: 14999750 [TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application. Veltkamp SA; Alderden-Los C; Sharma A; Rosing H; Beijnen JH; Schellens JH Cancer Chemother Pharmacol; 2007 Jan; 59(1):43-50. PubMed ID: 16680462 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Arndt CA; Colvin OM; Balis FM; Lester CM; Johnson G; Poplack DG Cancer Res; 1987 Nov; 47(22):5932-4. PubMed ID: 3664493 [TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Brem H; Piantadosi S; Burger PC; Walker M; Selker R; Vick NA; Black K; Sisti M; Brem S; Mohr G Lancet; 1995 Apr; 345(8956):1008-12. PubMed ID: 7723496 [TBL] [Abstract][Full Text] [Related]
20. Polymer chemotherapy for head and neck cancer. Shikani AH; Domb AJ Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]